Search for other papers by Matthew J. Brooks in
Google Scholar
PubMed
Search for other papers by David A. Pattison in
Google Scholar
PubMed
Search for other papers by Eliza P. Teo in
Google Scholar
PubMed
Search for other papers by Sarah Price in
Google Scholar
PubMed
Search for other papers by Ronen Gurvitch in
Google Scholar
PubMed
, Martino E: Glucocorticoid response in amiodarone-induced thyrotoxicosis resulting from destructive thyroiditis is predicted by thyroid volume and serum-free thyroid hormone concentrations. J Clin Endocrinol Metab 2007;92:556. 10.1210/jc.2006-2059 17148557
Search for other papers by Georgios K. Markantes in
Google Scholar
PubMed
Search for other papers by Marina A. Michalaki in
Google Scholar
PubMed
Search for other papers by George A. Vagenakis in
Google Scholar
PubMed
Search for other papers by Fotini N. Lamari in
Google Scholar
PubMed
Search for other papers by Efthymia Pitsi in
Google Scholar
PubMed
Search for other papers by Maria Eliopoulou in
Google Scholar
PubMed
Search for other papers by Nicholas G. Beratis in
Google Scholar
PubMed
Search for other papers by Kostas B. Markou in
Google Scholar
PubMed
pathogenic mechanisms: type 1 (AIT1) is a form of iodine-induced hyperthyroidism in response to the high iodine load present in amiodarone, while type 2 (AIT2) is a drug-induced destructive thyroiditis. There are also mixed forms, in which both pathogenic
Search for other papers by Alessandro Brancatella in
Google Scholar
PubMed
Search for other papers by Nicola Viola in
Google Scholar
PubMed
Search for other papers by Sandra Brogioni in
Google Scholar
PubMed
Search for other papers by Lucia Montanelli in
Google Scholar
PubMed
Search for other papers by Chiara Sardella in
Google Scholar
PubMed
Search for other papers by Paolo Vitti in
Google Scholar
PubMed
Search for other papers by Claudio Marcocci in
Google Scholar
PubMed
Search for other papers by Isabella Lupi in
Google Scholar
PubMed
Search for other papers by Francesco Latrofa in
Google Scholar
PubMed
-deficient diabetes mellitus, and primary adrenal insufficiency. Thyroid dysfunction is the most common ICPi-induced endocrinopathy, with transient thyrotoxicosis due to destructive thyroiditis and hypothyroidism frequently reported in clinical trials of ICPis. On the
University of Lille, Lille, France
Search for other papers by Hippolyte Dupuis in
Google Scholar
PubMed
Search for other papers by Emilie Merlen in
Google Scholar
PubMed
University of Lille, Lille, France
Search for other papers by Arnaud Jannin in
Google Scholar
PubMed
Department of Dermatology, Lille University Hospital, Lille, France
Search for other papers by Philippe Jamme in
Google Scholar
PubMed
Search for other papers by Alexandre Fagart in
Google Scholar
PubMed
University of Lille, Lille, France
Search for other papers by Marie-Christine Vantyghem in
Google Scholar
PubMed
Search for other papers by Miriam Ladsous in
Google Scholar
PubMed
Established facts Immune checkpoint inhibitors (ICI) can induce endocrine side effects, the most common of which is thyroid dysfunction. The main pathological mechanism of ICI-induced thyroid dysfunction is destructive thyroiditis
Search for other papers by Hideyuki Imai in
Google Scholar
PubMed
Search for other papers by Natsuko Watanabe in
Google Scholar
PubMed
Search for other papers by Rei Hirose in
Google Scholar
PubMed
Search for other papers by Masakazu Koshibu in
Google Scholar
PubMed
Search for other papers by Masahiro Ichikawa in
Google Scholar
PubMed
Search for other papers by Akiko Sankoda in
Google Scholar
PubMed
Search for other papers by Shigenori Hiruma in
Google Scholar
PubMed
Search for other papers by Nami Suzuki in
Google Scholar
PubMed
Search for other papers by Masako Matsumoto in
Google Scholar
PubMed
Search for other papers by Miho Fukushita in
Google Scholar
PubMed
Search for other papers by Ai Yoshihara in
Google Scholar
PubMed
Search for other papers by Jaeduk Yoshimura Noh in
Google Scholar
PubMed
Search for other papers by Kiminori Sugino in
Google Scholar
PubMed
Search for other papers by Koichi Ito in
Google Scholar
PubMed
, and the dose was increased to prednisolone 13 mg per day. Three patients (43%) received replacement therapy with LT4 for hypothyroidism following destructive thyroiditis due to SAT. The course of delivery and postpartum thyroid function were confirmed
Search for other papers by Alessandro Brancatella in
Google Scholar
PubMed
Search for other papers by Laura Pierotti in
Google Scholar
PubMed
Search for other papers by Nicola Viola in
Google Scholar
PubMed
Search for other papers by Isabella Lupi in
Google Scholar
PubMed
Search for other papers by Lucia Montanelli in
Google Scholar
PubMed
Search for other papers by Chiara Cremolini in
Google Scholar
PubMed
Search for other papers by Paolo Piaggi in
Google Scholar
PubMed
Search for other papers by Antonio Chella in
Google Scholar
PubMed
Search for other papers by Andrea Antonuzzo in
Google Scholar
PubMed
Search for other papers by Daniele Sgrò in
Google Scholar
PubMed
Search for other papers by Lucia Antonangeli in
Google Scholar
PubMed
Search for other papers by Chiara Sardella in
Google Scholar
PubMed
Search for other papers by Sandra Brogioni in
Google Scholar
PubMed
Search for other papers by Claudio Marcocci in
Google Scholar
PubMed
Search for other papers by Ferruccio Santini in
Google Scholar
PubMed
Search for other papers by Francesco Latrofa in
Google Scholar
PubMed
responsive to anti-thyroid drugs and a type 2, more common, characterized by a painless destructive thyroiditis that usually has a self-limited course ( 6 ). In addition, we have shown an association between enlarged thyroid volume and severity and duration
Search for other papers by Luigi Bartalena in
Google Scholar
PubMed
Search for other papers by Fausto Bogazzi in
Google Scholar
PubMed
Search for other papers by Luca Chiovato in
Google Scholar
PubMed
Search for other papers by Alicja Hubalewska-Dydejczyk in
Google Scholar
PubMed
Search for other papers by Thera P. Links in
Google Scholar
PubMed
Search for other papers by Mark Vanderpump in
Google Scholar
PubMed
gland with pre-existing abnormalities (nodular goitre, latent Graves disease, chronic autoimmune thyroiditis) [ 2 ]. The epidemiology of AIT has changed over a period of 25 years in Italy, as the prevalence of AIT due to destructive thyroiditis (see
Search for other papers by Eijun Nishihara in
Google Scholar
PubMed
Search for other papers by Nobuyuki Amino in
Google Scholar
PubMed
Search for other papers by Takumi Kudo in
Google Scholar
PubMed
Search for other papers by Kazuyoshi Kohsaka in
Google Scholar
PubMed
Search for other papers by Mitsuru Ito in
Google Scholar
PubMed
Search for other papers by Shuji Fukata in
Google Scholar
PubMed
Search for other papers by Mitsushige Nishikawa in
Google Scholar
PubMed
Search for other papers by Hirotoshi Nakamura in
Google Scholar
PubMed
Search for other papers by Akira Miyauchi in
Google Scholar
PubMed
TgAb and/or TPOAb in subacute thyroiditis in the individuals examined Painful Hashimoto’s thyroiditis shows overlapping clinical features such as destructive thyroiditis with inflammatory findings and presence of anti-thyroid antibodies. However
Search for other papers by Tumay Ozgur in
Google Scholar
PubMed
Search for other papers by Hasan Gokce in
Google Scholar
PubMed
Search for other papers by Ihsan Ustun in
Google Scholar
PubMed
Search for other papers by Mehmet Yaldiz in
Google Scholar
PubMed
Search for other papers by Mehmet Mustafa Akin in
Google Scholar
PubMed
Search for other papers by Cumali Gokce in
Google Scholar
PubMed
What Is Known about This Topic • Riedel thyroiditis is a rare disorder. • Riedel thyroiditis has been associated with other thyroid conditions like chronic lymphocytic thyroiditis, hypothyroidism, hyperthyroidism ad anaplastic carcinoma
Search for other papers by Anthony P. Weetman in
Google Scholar
PubMed
, Hashimoto thyroiditis has become the archetype of autoimmune destructive disorders and autoantibody production. This lecture honours Professor Aldo Pinchera, who has made many important contributions to our understanding of thyroid autoimmunity; remarkably